Healthcare

RNA Technologies Enabling Drug Discovery and Development

Redefining the Future of Healthcare through Groundbreaking RNA Therapies

INDUSTRY
Healthcare

RELEASE DATE
28-Dec-2018
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
D86A-01-00-00-00
SKU
HC03117-GL-TR_22716
Yes
SHARE

RNA Technologies Enabling Drug Discovery and Development
Published on: 28-Dec-2018 | SKU: HC03117-GL-TR_22716

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This research service encompasses a comprehensive analysis of RNA therapy industry from the following perspectives:
•     Industry Drivers and Challenges
•     Technology Snapshot and Trends
•     Clinical Pipeline Analysis
•     Overview of the IP Landscape
•     Innovator Profiles
•     Future Roadmap
The RNA therapy platforms covered include:
•     Splice-Switching Oligonucletides (SSO)
•     Other Anti-Sense Oligonucleotide (ASO)
•     Aptamers
•     RNA-interference
•     mRNA
•     saRNA
An appendix is included, comprising lists of major industry influencers found in the study.

1.1 Research Scope: RNA Therapies Redefining the Healthcare Landscape

1.2 Analysis Framework: Frost & Sullivan’s Core Value

1.3 Research Methodology: Five Steps Towards Success

1.4 Key Findings

2.1 RNA is the Rising Star of Transformative Therapy Platforms

2.2 Industry Accelerators and Challenges

2.3 RNA Delivery: Technology Segmentation

2.4 RNA Therapies: Technology Segmentation

2.5 Molecular Insights Across RNA Therapy

3.1 Alternative Splicing Induced by SSO Therapies

3.2 Clinical Pipeline Analysis for SSO Therapies for SMA and DMD

3.3 Post-transcriptional Modifications by ASO

3.4 Clinical Pipeline Overview for ASO Therapies

3.5 Emerging Clinical Pipeline for ASO Therapies

3.6 Early Phase ASO Therapies

3.7 Inhibition of Ligand Binding by Aptamer

3.8 Clinical Pipeline Analysis for Aptamer Therapies

3.9 Landmark Year for RNA Interference Therapy Platform

3.10 Clinical Analysis of RNA Interference Therapeutics

3.11 Overview of the Emerging Landscape for mRNA Therapies

3.12 Clinical Pipeline Analysis of mRNA Therapies

3.13 saRNA: The Rising Participant in RNA-based Therapies

4.1 Patenting Trends for ASO Technologies

4.2 Patenting Trends for RNAi Platforms

4.3 Patenting Trends for mRNA Technologies

5.1 Targeted RNAi Technology for Enhanced Disease Management

5.2 Enabling Targeted Delivery of RNAi Therapeutics

5.3 Developing Stable and Non-immunogenic mRNA Therapies

5.4 Fueling Novel RNA Therapy and Delivery Platforms

5.5 Enabling Potent Antisense Therapeutics

6.1 RNA Platforms likely to Transform the Future of Health & Wellness

6.2 Navigating Through The Future Landscape for RNA Technologies

7.1 Growth Opportunity 1: ASO Therapies

7.2 Growth Opportunity 2: RNAi Therapies

7.3 Growth Opportunity 3: mRNA Therapies

7.4 Strategic Imperatives for Success and Growth

8.1 Industry Interactions

8.1 Industry Interactions (continued)

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.